TikTok's Hottest Trend: Jaca Jolt from Healthy For Life Foods Sparks a Viral Sensation
Jaca Jolt, sold in a 12-pack of 2 fl oz shots, combines caffeine with essential vitamins B6 and B12 to deliver fast, effective, and long-lasting energy. Its unique formulation is sweetened with Jaca, a 100% pure form of Allulose—a rare sugar with powerful functional benefits. Unlike traditional energy drinks, Jaca Jolt contains no harmful sugar or alternative sweeteners, has zero net carbs, and zero glycemic impact, making it both keto-friendly and diabetic-safe
The star ingredient, Allulose, is GRAS-certified by the FDA (Generally Recognized As Safe) and is associated with a range of health benefits, including support for appetite control and fat burning. With only 5 calories, Jaca Jolt is designed to fit seamlessly into any lifestyle—whether you're at the gym, in meetings, on campus, or managing a full household.
'Jaca Jolt is built for people who live life on the go, and unlike many 2 ounce bottle drinks, is safe for all ages,' said Pete Ferrari, President at Healthy For Life Foods. 'We wanted to create an energy solution that delivers real results—without harmful old school sugar, without excessive amounts of caffeine and other harmful ingredients, without the crash, and without compromise. Seeing our Jaca Jolt go viral on TikTok has been incredibly rewarding. '
The response has been organic and explosive. TikTok videos tagged with #JacaJolt have collectively drawn millions of views. One trending video highlights the caption: 'POV: You're a mom working 12-hour night shifts,' is striking a chord with viewers seeking reliable energy support. Comment sections are filled with praise for its refreshing taste, jitter-free effect, and clean ingredient list. As one user posted, 'Jaca Jolt is a game-changer—no crash, just focus and stamina!'
Whether you're an athlete, a student, a busy parent, or a professional, Jaca Jolt is redefining how we think about energy. It's not just a boost—it's wellness-powered performance.
Jaca Jolt is available now at jacasugar.com. With Healthy For Life Foods leading the charge, this Allulose-powered shot is setting a new standard for energy supplements—and TikTok can't get enough of it.
About Healthy For Life Foods and Jaca Sugar
Healthy For Life Foods is a health and wellbeing company that pioneered the introduction of Allulose—a rare sugar and superfood—to the U.S. market at scale. Through its brand Jaca, HFLF is committed to creating innovative and functional products that support energy, appetite balance, and overall wellness.
Jaca (Healthy For Life Foods)
Media Contact
Company Name: Healthy For Life Foods
Contact Person: Pete Ferrari
Email: Send Email
City: Delray Beach
State: FL
Country: United States
Website: https://jacasugar.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
2 hours ago
- CTV News
Pura Scents recalling more than 850,000 diffusers as magnet issue may cause ingestion hazard
Pura Scents is recalling more than 850,000 diffusers because some magnets may detach and cause a possible ingestion hazard to children. The company is recalling about 851,400 Pura 4 Smart Home Fragrance Diffusers with detachable covers. It said an additional 1,100 were sold in Canada. Pura Scents said that the magnets on the inside cover of the product can detach, posing an ingestion hazard to children. When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting or blockage of the intestines, infection, blood poisoning and death. The company has received three reports of magnets detaching from the cover. No injuries have been reported. The diffusers were sold at Target, Scheels and other stores nationwide from August 2023 through May 2025 for about US$50. They were also sold online through Pura's website, as well as online at Amazon, Target and Scheels. Pura Scents is offering a free replacement cover. Consumers are advised to immediately dispose of the existing detachable cover and to keep the diffusers out of the reach of children and pets. To receive the free replacement cover, individuals may contact Pura Scents at 855-394-5292 from 9 a.m. to 5 p.m. MT Monday through Friday. The company can also be emailed at replacement@ Consumers may also visit the company's website and click on 'Recall' at the bottom of the page for more information. Michelle Chapman, The Associated Press
Globe and Mail
3 hours ago
- Globe and Mail
How Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?
Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company's primary focus is on diabetes and obesity drugs, the oncology franchise also remains a key contributor to the top line. Sales from the oncology segment accounted for over 15% of Lilly's first-quarter revenues, which grew more than 11% year over year. Our model estimates second-quarter 2025 sales for the overall oncology unit to be $2.4 billion, indicating more than 11% year-over-year growth. A significant portion of these revenues is likely to have been generated from sales of the company's blockbuster breast cancer drug, Verzenio. Sales of this drug are expected to have been driven by increased demand and higher realized prices during the quarter, partially offset by currency headwinds and competitive dynamics. Sales of RET inhibitor Retevmo and newer lymphoma drug Jaypirca are also likely to have contributed positively to top-line growth during the quarter. However, these gains might have been partially offset by the declining sales of older cancer drugs like Alimta and Cyramza, which are being impacted by competition from immuno-oncology agents in the United States. Though Lilly's oncology portfolio is contributing meaningfully, investor focus will largely remain on blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity). Investors will closely track their sequential growth and market share trends in the upcoming second-quarter results on Aug. 7. Competition in the Oncology Space Other bigger players in this area are AstraZeneca AZN, Merck MRK and Pfizer PFE. For AstraZeneca, oncology sales now account for nearly 41% of total revenues. Growth in AZN's oncology franchise is being driven by medicines such as Tagrisso, Lynparza, Imfinzi, Calquence and Enhertu (in partnership with Daiichi Sankyo). Merck's key oncology medicines are PD-1 inhibitor, Keytruda and PARP inhibitor, Lynparza, which it markets in partnership with AstraZeneca. Keytruda, approved for several types of cancer, alone accounts for nearly half of Merck's product revenues. Pfizer's oncology segment — comprising drugs like Xtandi, Lorbrena, the Braftovi-Mektovi combination and Padcev — currently accounts for more than 27% of its total revenues. LLY's Price Performance, Valuation and Estimates Shares of Lilly have outperformed the industry year to date, as seen in the chart below. From a valuation standpoint, Eli Lilly is expensive. Based on the price/earnings (P/E) ratio, the company's shares currently trade at 29.66 times forward earnings, higher than its industry's average of 14.91. However, the stock is trading below its five-year mean of 34.54. EPS estimates for 2025 have risen from $21.92 to $21.99, while those for 2026 have declined from $30.91 to $30.79 over the past 30 days. Eli Lilly currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report Merck & Co., Inc. (MRK): Free Stock Analysis Report Eli Lilly and Company (LLY): Free Stock Analysis Report
CTV News
3 hours ago
- CTV News
Pura Scents recalling more than 850,000 diffusers as magnet issue may cause ingestion hazard
Pura Scents is recalling more than 850,000 diffusers because some magnets may detach and cause a possible ingestion hazard to children. The company is recalling about 851,400 Pura 4 Smart Home Fragrance Diffusers with detachable covers. It said an additional 1,100 were sold in Canada. Pura Scents said that the magnets on the inside cover of the product can detach, posing an ingestion hazard to children. When high-powered magnets are swallowed, the ingested magnets can attract each other, or other metal objects, and become lodged in the digestive system. This can result in perforations, twisting or blockage of the intestines, infection, blood poisoning and death. The company has received three reports of magnets detaching from the cover. No injuries have been reported. The diffusers were sold at Target, Scheels and other stores nationwide from August 2023 through May 2025 for about US$50. They were also sold online through Pura's website, as well as online at Amazon, Target and Scheels. Pura Scents is offering a free replacement cover. Consumers are advised to immediately dispose of the existing detachable cover and to keep the diffusers out of the reach of children and pets. To receive the free replacement cover, individuals may contact Pura Scents at 855-394-5292 from 9 a.m. to 5 p.m. MT Monday through Friday. The company can also be emailed at replacement@ Consumers may also visit the company's website and click on 'Recall' at the bottom of the page for more information. Michelle Chapman, The Associated Press
